| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,053 | 101,834 | 116,802 | 147,616 | | Cost of Revenue | 65,280 | 68,437 | 79,818 | 99,061 | | | Gross Profit | 32,773 | 33,397 | 36,984 | 48,555 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,451 | 29,985 | 33,129 | 38,229 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,322 | 3,412 | 3,855 | 10,326 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34 | 47 | 56 | (226) | | Earnings Before Interest And Taxes | 4,356 | 3,459 | 3,911 | 10,100 | | Interest Expense | 1,777 | 2,059 | 1,087 | 2,647 | | Income Before Tax | 2,579 | 1,400 | 2,824 | 7,453 | | Income Tax Expense | 1,125 | 830 | 1,176 | 3,915 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,454 | 570 | 1,648 | 3,538 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,454 | 570 | 1,648 | 3,538 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,454 | $570 | $1,648 | $3,538 |
|
0.11% Nasdaq 
0.01%
Income Statement
